Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 New Entrants companies in Monoclonal antibody
by Most Patent Filing In 3 Years in the United States in 2022

The Monoclonal antibody top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 3 Years Monoclonal antibody New Entrants in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
#
Company Name
Region
Tech Topics
Total
1
Verseau Therapeutics, Inc.
Pharmacy and Therapeutics,Oncology drugs,Biopharmaceutical,
...[+2]
Patent: 29
2
Phanes Therapeutics, Inc.
Drug,Biotechnology,Medicine,
...[+2]
Patent: 8
3
KLUS Pharma, Inc.
Antibody,Drug discovery
Patent: 5
4
Shanghai Genbase Biotechnology Co. Ltd.
Patent: 5
5
Momenta Pharmaceuticals, Inc.
Medicine,Health care,Molecule,
...[+2]
Patent: 4
6
HCW Biologics Inc.
Cellular senescence,Health care,Immunotherapy
Patent: 4
7
10X Genomics, Inc.
Genomics,Health care,Cell,
...[+2]
Patent: 3
8
Yurogen Biosystems LLC
Monoclonal antibody,Contract research organization,Clinical trial
Patent: 3
9
Navrogen, Inc.
Biology,Medicine,Cancer,
...[+2]
Patent: 3
10
Electra Therapeutics, Inc.
Cell,Myeloid,Secondary Hemophagocytic Lymphohistiocytosis,
...[+1]
Patent: 2
Page generation time: Jul 19 2025